Binding protein-3-selective insulin-like growth factor I variants: Engineering, biodistributions, and clearance

Endocrinology

Volumn 142, Issue 1, 2001, Pages 165-173

  Dubaquié, Yves ^a   Mortensen, Deborah L ^a   Intintoli, Anthony ^a   Hogue, Deborah A ^a   Nakamura, Gerald ^a   Rancatore, Patricia ^a   Lester, Philip ^a   Sadick, Michael D ^a   Filvaroff, Ellen ^a   Fielder, Paul J ^a   Lowman, Henry B ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; CHO CELL; CIRCULAR DICHROISM; DIABETES MELLITUS; LIVER FAILURE; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN VARIANT; RECEPTOR AFFINITY; TISSUE DISTRIBUTION;

EID: 17744369458     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7864     Document Type: Article

References (43)

1. Insulin-like growth factors and their binding proteins: Biological Actions
2. Insulin-like growth factors
3. Insulin-like growth factor 1 receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
4. Regulation and actions of the insulin-like growth factor binding proteins
5. Insulin-like growth factor binding proteins
6. Cellular actions of insulin-like growth factor binding proteins
7. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily
8. Insulin-like growth factor binding protein proteolysis in bone cell models
9. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3
10. Structural determinants of ligand and cell-surface binding of insulin-like growth factor-binding protein-3
11. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
12. Insulin-like growth factor binding proteins and their role in controlling IGF action
13. Insulin-like growth factor binding protein-1 induces insulin release in the rat
14. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia
15. Efficient site-directed mutagenesis using uracil-containing DNA
16. Total alanine-scanning mutagenesis of insulin-like growth factor I (IGF-I) identifies differential binding epitopes for IGFBP-1 and IGFBP-3
17. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein
18. High-performance immunosorbent purification of recombinant leukocyte A interferon
19. High molecular weight insulin-like growth factor binding protein complex
20. Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein
21. Measurement of the acid-labile subunit of the insulin-like growth factor binding protein complex in human serum: A comparison of four immunoassays
22. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange
23. Kinase receptor activation (KIRA): A rapid and accurate alternative to endpoint bioassays
24. Kinase receptor activation (KIRA): A rapid and accurate alternative to end-point bioassays
25. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissue
26. Additivity of mutational effects in proteins
27. Solution structure of human insulin-like growth factor I: A nuclear magnetic resonance and restrained molecular dynamics study
28. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-receptor
29. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis
30. Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor
31. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor
32. Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke
33. Molecular mimics of insulin-like growth factor I (IGF-I) for inhibiting IGF-I: IGF-binding protein interactions
34. Oxidative refolding of insulin-like growth factor I yields two products of similar thermodynamic stability: A bifurcating protein-refolding pathway
35. A spectroscopic investigation of the conformational dynamics of insulin in solution
36. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs
37. N-Linked glycosylation and sialylation of the acid-labile subunit
38. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats
39. Plasma clearance and tissue distribution of labeled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats
40. 3IGF-I in pregnant rats
41. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid
42. The insulin-like growth factors (IGFs) I and II bind to articular cartilage via the IGF-binding proteins
43. Insulin-like growth factor I and its binding proteins 3 and 4 are increased in human inflammatory synovial fluid